We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 534

Roche Vs Cipla: Final leg of battle over Tarceva Patent
  • RNA, Intellectual Property Attorneys
  • India
  • February 2 2016

In the final leg of battle over Tarceva patent, Cipla has approached Supreme Court challenging High Court's Order holding it guilty of infringing


Sidley Global Pricing newsletter - V4 2016
  • Sidley Austin LLP
  • Spain, Sweden, United Kingdom, USA, China, European Union, France, Germany, India, Netherlands, Australia, Belgium, Canada
  • January 27 2016

The Australian Pharmaceutical Benefits Pricing Authority (PBPA) ceased operations on April 1, 2014, in a move by the government to improve drug


Lee pharma’s compulsory license application for saxagliptin rejected by Indian Patent Office
  • Khaitan & Co
  • India
  • January 22 2016

In an order dated 19 January 2016 (Order), the Controller General of Patents and Trademarks (CGPTM) rejected the application for Compulsory License


Stability per se of a Salt not a Patentable subject matter
  • RNA, Intellectual Property Attorneys
  • India
  • January 7 2016

This article summarises the recent decision of Indian Patent Office on a pre grant opposition filed by Lupin Ltd, a well known Indian Pharmaceutical


Diagnosis by drug reps - India's health camps
  • Leigh Day
  • India, United Kingdom
  • December 17 2015

A report by the British Medical Journal has found that pharmaceutical representatives are completing screening and diagnostic testing in return for


CCI initiates investigation against Max Super Specialty Hospitals for alleged abuse of dominance
  • Vaish Associates Advocates
  • India
  • December 14 2015

The CCI in its order dated November 17, 2015, has directed the Director General (DG) to conduct an investigation against Max Super Specialty Hospital


Biotechnological inventions in India: law, practice and challenges
  • Remfry & Sagar
  • India
  • October 23 2015

Indian patent filing and jurisprudence in the biotech domain have seen neither the volume nor the attention enjoyed by the pharmaceuticals and


Prior registration of a mark is of no assistance if the use of the same is commenced after twelve year
  • Khaitan & Co
  • India
  • October 13 2015

The Supreme Court of India (Supreme Court), giving credence to the 'first in the market' test, has passed a significant decision in the case of Neon


Competition law as panacea for high prices?
  • Bristows LLP
  • European Union, India, United Kingdom
  • October 12 2015

It seems that the CMA's opening of an investigation into Pfizer Flynn (which we discussed here) may not be the only pending competition case on


Sun Pharma v Psycoremedies
  • RNA, Intellectual Property Attorneys
  • India
  • October 7 2015

Madras High Court considers impact of twelve years of use and co-existence to set aside the ex parte interim injunction granted on the basis of prior